The complicated task of monitoring vaccine safety

Public Health Reports

Volumn 112, Issue 1, 1997, Pages 10-19

  Ellenberg, Susan S ^a,c   Chen, Robert T ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; DRUG SAFETY; IMMUNIZATION; INFECTION PREVENTION; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 0031024804     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Waldman RH, Kluge RM, editors. Textbook of infectious diseases. New Hyde Park (NY): Medical Examination Publishing Co., 1984: 4.
2. Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Mortimer EA, editors. Vaccines. Philadelphia: WB Saunders, 1994:1-12.
3. Prevots DR, Sutter RW, Stickel PM, et al. Completeness of reporting for paralytic poliomyelitis, United States, 1980-1991. Arch Pediatr Adolesc Med 1994;148:479-485.
4. U.S. changes policy on polio inoculation, recommending Salk vaccine for first doses. New York Times 1996 Sep 20; Sec. A:18.
5. Coulter HL, Fisher BL. DPT, a shot in the dark. New York: Warner Books, 1985.
6. Kimura M, Kuno-Sakai H. Developments in pertussis immunization in Japan. Lancet 1990;336:30-32.
7. Miller D, Madge N, Diamond J, Wadsworth J, Ross E. Pertussis immunization and serious acute neurological illnesses in children. BMJ 1993;307:1171-1176.
8. Krantz I, Taranger J, Trollfors B. Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Int J Epidemiol 1989;18:959-963.
9. Hinman AR. DTP vaccine litigation. Am J Dis Child 1986;140: 528-530.
10. Mariner WK, Clark ME. Confronting the immunization problem: proposals for compensation reform. Am J Public Health 1986;76: 703-708.
11. Centers for Disease Control and Prevention [US]. Diphtheriatetanus-pertussis vaccine shortage-United States. MMWR Morb Mortal Wkly Report 1984;33:695-696.
12. National Childhood Vaccine Injury Act of 1986, at Section 2125 of the Public Health Service Act as codified at 42 U.S.C. § 300aa-(Supp.1987).
13. Flamberg G. An experiment in tort reform. Public Health Rep 1995;110:635-638.
14. Howson CP, Howe CJ, Fineberg HV, editors. Adverse effects of pertussis and rubella vaccines. Washington DC: National Academy Press, 1991.
15. Stratton KR, Howe CJ, Johnston RB Jr., editors. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington DC: National Academy Press, 1994.
16. Centers for Disease Control and Prevention [US]. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination. MMWR Morb Mortal Wkly Report 1988;37:197-200.
17. Chen RT, Rastogi SC, Mullen JR, Hayes S, Cochi SL, Donlon JA, Wassilak SG. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994;12:542-550.
18. Kessler DA. Introducing MEDWatch. JAMA 1993;269:2765-2768.
19. Bankowski Z, Dunne JF, editors. Drug surveillance: international cooperation past, present and future. Proceedings of the XXVIIth Council for International Organizations of Medical Science Conference; 1993 Sep 14-15; Geneva, Switzerland. Geneva: CIOMS, 1994.
20. Herrington DA. Initial clinical evaluation of new vaccine candidates. In: Woodrow GC, Levine MM, editors. New generation vaccines. New York: Marcel Dekker, 1990:43-49.
21. Parkman PD, Hardegree MC. Regulation and testing of vaccines. In: Plotkin SA, Mortimer EA, editors. Vaccines. Philadelphia: W.B. Saunders, 1994;889-902.
22. Clemens JD, Stanton BF. Longer term evaluation of vaccine efficacy. In: Woodrow GC, Levine MM, editors. New generation vaccines. New York: Marcel Dekker, 1990;51-68.
23. Faich GA. Adverse drug reaction monitoring. N Engl J Med 1986;314:1589-1592.
24. Stetler HC, Mullen JR, Brennan JP, Livengood JR, Orenstein WA, Hinman AR. Monitoring system for adverse events following immunization. Vaccine 1987;5:169-174.
25. Braun MM, Ellenberg SS. Descriptive epidemiology of adverse events following immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994. J Peds. In press.
26. Centers for Disease Control and Prevention [US]. Recommended childhood immunization schedule. MMWR Morb Mortal Wkly Report 1996; 44:940-943.
27. Niu, MT, Davis, DM, Ellenberg, SS. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System (VAERS). Pediatr Infect Dis J 1996;15:771-776.
28. Hoffman HJ, Hunter JC, Damus K, Parker J, Peterson DR, van Bell G, Hasselmeyer EG. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Pediatr 1987;79:598-611.
29. NBC Now [television]. Adverse reactions to vaccines. 1995 Mar 2.
30. Hoffman HJ, Hilman LS. Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postnatal risk factors. Clin Prenatol 1992;19:717-737.
31. Ponsonby A-L, Dwyer T, Gibbons LE, Cochrane JA, Wang Y-G. Factors potentiating the risk of sudden infant death syndrome associated with the prone position. New Eng J Med 1993;329:377-382.
32. Klonoff-Cohen, HS, Edelstein, SL, Lefkowitz, ES, Srinivasan, IP, Kaegi, D, Chang, JC, Wiley, KJ. The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA 1995;273:795-798.
33. Wigfield RE, Fleming PJ, Berry PJ, Rudd PT, Golding J. Can the fall in Avon's sudden infant death rate be explained by changes in sleeping positions? BMJ 1992;304:282-283.
34. Dwyer T, Ponsonby AL, Blizzard L, Newman NM, Cochrane JA. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA 1995;273:783-789.
35. Mitchell EA, Brunt JM, Evard C. Reduction in mortality from sudden infant death syndrome in New Zealand. Arch Dis Child 1994;70:291-294.
36. Spiers, PS, Guntheroth WG. Recommendations to avoid the prone sleeping position and recent statistics for sudden infant death syndrome in the United States. Arch Pediatr Adolesc Med 1994;148: 141-146.
37. Willinger M. Sleep position and sudden infant death syndrome. JAMA 1995;273:818-819.
38. National Vaccine Information Center. Vaccine Adverse Event Reporting System (VAERS) - DPT vaccine report: master list of lot numbers. 1994.
39. 21 CFR 610
40. Beeler, J, Varricchio, F, Wise, RP. Thrombocytopenia following immunization with measles vaccines. Pediatr Infect Dis J 1996;15: 1019-1030.
41. Wise RP, Kiminyo KP. Postvaccinal alopecia: recognition through passive surveillance [abstract]. Pharmacoepidemiology and Drug Safety 1995;4:S79.
42. Braun MM, Patriarca P, Ellenberg SS. Syncope after immunization. Arch Pediatr Adolesc Med. In press.
43. Rosenthal S, Chen R, Hadler SC. The safety of acellular pertussis vaccine versus whole cell pertussis vaccine: a post-marketing assessment. Arch Pediatr Adolesc Med 1996;150:457-460.
44. Centers for Disease Control and Prevention [US]. Food and Drug Administration approval of use of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Report 1991;40:881-882.
45. Centers for Disease Control and Prevention [US]. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series; update to supplementary ACIP statement. MMWR Morb Mortal Wkly Report 1992;41:(RR-15);1-5.
46. Chen RT, Haber P, Mullen JR. Surveillance of the safety of simultaneous administration of vaccines: the CDC experience. Ann NY Acad Sci 1995;754:309-320.
47. Rosenthal S, Chen RT. Reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health 1995;85:1706-1709.
48. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev 1990;12:87-107.
49. Chen RT, Glasser J, Rhodes P, Thompson RS, Mullooly JP, Black SB, et al. The Vaccine Safety Datalink Project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. In press.
50. Terracciano G, Schonberger L, Chen RT, Dury E, Lasky T, Koski CL, et al. Accuracy of measurement of a rare vaccine-associated adverse event using hospital discharge data: Guillain-Barré syndrome [abstract]. Pharmacoepidemiology and Drug Safety 1996;5:548.
51. Williams JC, Goldenthal KL, Burns DL, Lewis BP Jr., editors. Combined vaccines and simultaneous administration: current issues and perspectives. Ann New York Acad Sci 1995;754:XI-XV,1-404.